Postmenopausal Vaginal Atrophy Drugs Market by Therapy Type and Drug Forms, Forecast 2023
Postmenopausal vaginal atrophy (PVA) refers to the reduction in estrogen production after menopause and this condition is also called as vaginal atrophy. Less estrogen leads to thinning, drying, and decreased the elasticity of vaginal tissues. Various other factors that lead to the decrease in estrogen levels include perimenopause during breastfeeding, surgical menopause, pelvic radiation therapy, and chemotherapy. Symptoms of vaginal atrophy include redness, burning, itching, dyspareunia, and irritation. Diagnosis for PVA includes pelvic examination, vaginal smear test, vaginal activity test,...
View full press release